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Summary
The aim of this study was to analyze molecular fea-
tures of protease-resistant prion protein (PrPres) in
Western blots of BSE cases diagnosed in Poland with
respect to a possible atypical status. Confirmed cases
were analyzed by Western blotting with several
monoclonal antibodies directed at N-terminal and
core epitopes of prion protein (PrP). Most cases
showed the classical glycoprofile characterized by
the dominance of the di- over the monoglycosy-
lated PrPres band, yielding di-=mono- ratios well
above 2 and by reactivity with antibodies having
their epitopes in bovine PrP region 110–242 (C-
type cases). Surprisingly, seven cases of BSE were
atypical. Six were classified as L-type based on a
slightly lower molecular mass (Mr) of the non-
glycosylated band with respect to C-types and a
conspicuously low di-=mono- ratio of glycosylated
PrPres bands approaching unity. One case was clas-
sified as H-type because of a higher Mr of PrP
res
bands on the blot when compared with C-type
cases. A characteristic epitope of H-type PrPres oc-
curred in the 101–110 region of PrP for which only
antibody 12B2 had a sufficient affinity. The occur-
rence of atypical cases only in animals 9 years of
age and older raises questions about the mechan-
isms of prion diseases and the origin of BSE.
Introduction
A hallmark of prion diseases or transmissible spong-
iform encephalopthies (TSEs) is the deposition in
the brain and some other tissues of a protease-re-
sistant form of a host protein – prion protein (PrP).
Depending on the diagnostic technique, this ab-
berant form is termed differently: PrPd for describ-
ing the unusual and symmetrical depositions in
the brain, or PrPres as a molecular description for
the protease-resistant form in immunochemical
tests like enzyme-linked immunosorbent assay and
Western blot [22, 26, 36].
Despite the fact that bovine spongiform enceph-
alopathy (BSE) was described for the first time 20
years ago, there are still many issues related to the
causative agent and the origin of the disease that
are not fully elucidated [17, 18, 38, 39]. While at
the time of discovery it was a new disease in cows,
a similar disease in sheep, namely scrapie, has been
known for hundreds of years [7, 24]. Therefore,
scrapie is regarded as the prototype in a group of
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diseases called TSEs or prion diseases. Before the
BSE-derived variant of Creutzfeldt-Jakob disease
(vCJD) was recognized in humans, other forms of
TSEs in man were already known, such as kuru,
fatal familial insomnia (FFI), Gerstmann-Str€aussler-
Scheinker syndrome (GSS) and sporadic, iatrogenic
and familial forms of CJD [19].
In sheep, many strains have been described,
pointing to quite a variety of biological features
of the agent [11, 12]. On the other hand, although
more than 180,000 cases of BSE have been diag-
nosed in the UK and more than 5000 in continental
Europe, the agent from clinically affected animals
seems to be very stable during an epidemic, based
mostly on histology of brain lesions in cattle, but
also on a limited set of bioassay studies in mice
[9, 10, 16, 20, 23, 30, 38].
However, since 2003, unusual cases of BSE have
been reported in France, Italy, Belgium, Japan,
Germany, the United States and Switzerland [1, 6,
14, 17, 21, 35, 37, 42]. Those studies were mostly
based on unusual molecular features of PrPres like a
triple band pattern due to variations in glycosyla-
tion and migration positions because of variable,
but often strain-type-dependent, cleavage by pro-
teinase K. Two atypical forms of BSE have been
defined: H-type (higher position on the gel with
respect to classical BSE) and L-type (lower posi-
tion when compared with classical BSE) [25].
Unusual features of those atypical cases were fur-
ther confirmed in bioassay studies in both wild-type
and in transgenic mice [3, 5, 14, 15]. Despite a
species barrier, features of PrPres that were ob-
served previously in cows were also maintained
in mice. Similarities between PrPres from those atyp-
ical cases and the sporadic form of CJD (sCJD) in
man and scrapie in small ruminants triggered fur-
ther discussions about the origin of BSE [2, 6, 8,
17, 34]. Until now, no evident clinical features rem-
iniscent of a neurological disease have been avail-
able for these atypical cases. Their clinical histories
are not available because the detection was accom-
plished through active surveillance programs using
biochemical tests on healthy slaughtered and fallen
stock animals.
In Poland, the first case of BSE was detected in
a healthy cow in May 2002 by active surveillance
using postmortem testing, while until then no cases
were found in small-scale passive surveillance in
BSE-suspect animals conducted since 1996 [31, 33].
Until the end of 2006, 50 cases of BSE were diag-
nosed and confirmed in Poland. All of them were
found in native-born cattle of black-and-white
breed. An abberant glycoprofile of PrPres in an
older animal was already reported in 2004 [32].
Therefore, the objective of this study was to per-
form a retrospective analysis of the molecular fea-
tures of PrPres from all cases of BSE in search of
atypical glycoprofiles and to classify them according
to current knowledge and nomenclature. Positive
homogenates from confirmed UK cases were used
as reference material to get characteristics of classi-
cal BSE and to relate it to all available Polish cases.
In this paper, we report a striking occurrence of
atypical cases in a large fraction of BSE-infected
animals 9 years of age and older. For recognizing
H-type cases, N-terminus-specific antibody 12B2
appeared more suitable than antibody P4.
Materials and methods
Brain stem tissue
The majority of all positive cases were diagnosed initially
during active surveillance using one of three rapid tests.
Brain stem samples comprising the obex region were collect-
ed with a special spoon via foramen magnum. Confirmation
was based on histopathology and immunohistochemistry.
Only 2 out of 50 confirmed cases – ages 8 and 7 years – were
initially diagnosed during passive surveillance, using forma-
lin-fixed samples. Therefore, they were unsuitable for Western
blot (WB) analysis. Additionally, for quality assessments,
16 positive homogenates from confirmed British cases of
BSE, collected during passive surveillance, kindly provided
by the Community Reference Laboratory, Weybridge, UK,
were used in the study (UK samples) for comparison.
Western blot (WB)
Material suitable for WB from 48 Polish cases was analyzed
by means of a modified Prionics-Check Western (Prionics)
rapid test [36]. In short, 10% homogenates of obex samples
(w=v) were prepared in lysis buffer (0.5% Triton X-100,
0.5% sodium deoxycholate in 10 mM PBS, pH 7.2) using
an omni homogenizer (except for UK samples prepared in
Prionics homogenisation buffer). Next, 1 ml of each homog-
enate was centrifuged at 1000g for 5 min and supernatants
were collected. Digestion with proteinase K (Sigma, 50mg=
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ml) was done at 37 C for 60 min. After addition of digestion
stop buffer (Prionics), samples were precipitated with an
equal volume of 1-propanol (Sigma) as described [28].
Samples were centrifuged, supernatants were discarded and
sediments were resuspended in 1 sample buffer (Prionics).
The samples were denatured at 96 C for 5 min before load-
ing on 12% SDS-PAGE Bis-Tris gels (NuPAGE 12% Bis-
Tris gel, Invitrogen). Electrophoresis (sodium dodecyl sulfate
polyacrylamide gel electrophoresis – SDS-PAGE) was run in
MOPS buffer, initially at 150 V and after 15 min at 200 V,
until the dye reached the bottom of the gel. Molecular weight
standards (Sigma, Invitrogen) were loaded in each gel to
facilitate determination of the molecular mass of each form
of PrPres. Wet protein transfer (Western blot) to a poly-
vinylidene difluoride membrane (Immobilon P, Millipore)
was carried out at 150 V for 1 h at 4 C. The membranes
were incubated in blocking buffer (Prionics) for 30 min.
Incubation with monoclonal antibodies (mAbs) in TBST
(Tris-buffered saline supplemented with 0.05% Tween 20)
was performed for 60 min at room temperature on a rocking
platform. Primary antibodies used were: mAbs 6H4 and
94B4 as PrP-core-specific antibodies, and 9A2, 12B2, P4 as
N-terminus-specific antibodies [25, 27, 28, 36]. N-terminus-
specific rabbit serum RB1 was also used [29]. The mem-
branes were washed in TBST three times for 2 min each.
Then secondary antibody (goat anti-mouse conjugate cou-
pled with alkaline phosphatase, Prionics) was added at
1=5000 dilution in TBST, and the membranes were incubat-
ed for 30 min at room temperature with the addition of
streptavidin-alkaline phosphatase (Sigma) to reveal the mo-
lecular weight standards. The washings with TBST were
done five times for 2 min each. Chemiluminescence detec-
tion was performed according to the Prionics procedure, and
the membranes were developed on X-ray films after incuba-
tion with CDP-Star (Sigma) – an alkaline phosphatase sub-
strate. For quantitation of PrPres, films were digitally scanned
and subsequently analyzed using ONE-Dscan software ver-
sion 1.31 (Scanalytics). For each sample, the proportion of
di-, mono-, and non-glycosylated PrPres fractions were cal-
culated as percentages of total PrPres, and mean values
standard deviations (SD) were used for data analysis. Also,
migration patterns in these scans were used for apparent
mass determination of the respective forms of PrPres, in each
case by comparison with the migration distance of the mo-
lecular weight standard run on each gel. Each sample was
tested in several repetitions on several gels.
In some cases, PK-digested homogenates were further de-
glycosylated with 50 U of PNGaseF (New England Biolabs)
as described [25]. SDS-PAGE and Western blotting were car-
ried out as described above, using 9A2 as primary antibody.
Results
The data and graphs presented below for glycoform
contents and molecular masses were obtained with
antibody 6H4, except when explicitely indicated
otherwise.
C-types
Glycoprofiles and migration patterns of PrPres in
analyses of UK samples provided a basis for clas-
sification as classical BSE (C-type) cases (Fig. 1).
Mean proportions of the three forms of PrPres (di-,
mono- and nonglycosylated moieties) were res-
pectively 68, 24 and 8%. Apparent molecular
mass (Mr) estimates of PrP
res bands were as fol-
lows: 26.9, 21.2 and 17.2 kDa for the di-, mono-,
and non-glycosylated bands, respectively. Analysis
of PrPres from Polish cases of confirmed BSE
showed similar proportions of PrPres moieties in
Fig. 1. Molecular PrPres profiles of distinct groups of BSE
cases. (A) bar diagram for relative proportions of di- (dark),
mono- (grey), and non-glycosylated (white) PrPres fraction
expressed as percentage of all three fractions together.
(B) graph representing apparent molecular mass of di- (dia-
monds), mono- (squares), and non-glycosylated (circles)
PrPres bands. Values are given as averages SD
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41 out of 48 homogenates tested (Figs. 1 and 2).
These 41 cases, like the British cases, contain-
ed a high relative amount of the diglycosylated
form (62%) and much lower fractions of mono-
(27%) and nonglycosylated bands (11%). Mr of
di-, mono- and non-glycosylated PrPres moieties
were on average 27.2, 21.8 and 17.9 kDa, respec-
tively. The values differ from those obtained
above for the British cases, but they are still with-
in the range of variations measured for individual
samples between different experiments (interas-
say variation) (coefficient of variation equal to
2.4 kDa for UK samples and 1.3 kDa for Polish
samples).
These C-type isolates reacted with core antibod-
ies and with N-terminus-specific mAb 9A2 (epi-
tope mapped to 110–112 of bovine PrP). However,
there was hardly any reactivity with mAbs 12B2
and P4 (epitopes mapped respectively to amino
acids 101–105 and 101–107 of bovine PrP) lo-
cated further to the N-terminus of PrP (Fig. 3).
The age of these C-type cases ranged from 2 to
12 years.
The 7 remaining cases will be discussed in the
next paragraphs.
L-types
Different glycoprofiles were observed in 6 cases, all
from older cattle aged 9 years and more. Mean
proportions of the three forms of PrPres (di-, mono-
and non-glycosylated moieties) were 43, 38, and
19%, respectively (Fig. 1A). Thus, compared to
the C-type cases, the relative amount of diglycosy-
lated PrPres in L-types was lower, resulting in a
higher mono- and non-glycosylated fraction. The
Mr values of the di-, mono- and nonglycosylated
moieties were 26.7, 21.8 and 17.4 kDa, respectively
(Fig. 1B). This slightly faster migration of the non-
glycosylated band was not very obvious upon visu-
al inspection, but it was consistently present when
compared in the same run with C-type cases. Also,
a distinction could be made with mAb 6H4, but not
with 9A2 (Fig. 2). However, when compared to the
C-type cases, the low amount of the diglycosylated
form and higher amount of the monoglycosylated
form was a constant feature. The ratio between the
di- and monoglycosylated fractions was strikingly
invariant, showing only 5–10% fluctuation in the
diglycosylated=monoglycosylated ratio (D=M ra-
tio), which was lower than that found in the group
of C-type cases (Table 1).
Fig. 2. Immunostaining of PrPres in different BSE-types. (A) PrPres in Polish BSE cases of different type detected with a
core specific antibody 6H4. Migration characteristics of PrPres in Polish BSE-types loaded in duplicates (M molecular weight
standard; C C-type case; L L-type case; H H-type case). (B) PrPres in Polish BSE-cases of different type detected with an N-
terminus specific antibody 9A2. Every lane refers to one isolate except for C-type loaded twice (M molecular weight
standard; H H-type case; C C-type case; L L-type case)
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H-type
An additional type of PrPres was found in a 10-year-
old BSE cow. A striking feature in this case was a
higher Mr of all three bands, resulting in clearly
higher positions on the blot when using antibodies
with epitopes located in the 110–242 region of PrP.
The Mr values for di-, mono- and nonglycosylated
forms were 28.0, 23.0 and 18.8 kDa, respectively
(Fig. 1B). The glycoprofile of this case resembled
the classical type with 60% diglycosylated, 32%
monoglycosylated, and 8% nonglycosylated form
(Fig. 1A, Table 1). Due to higher migration of PrP
glycoforms in SDS-PAGE, this type of BSE was
termed H-type (Fig. 2).
Comparison of N-terminus-specific antibodies
for BSE-type discrimination
From the above it was evident that, in H-type BSE
cases, proteinase K cleaved the N-terminal domain
of PrP only till residue 101 or even closer to the
N-terminus of the bovine PrP sequence, instead of
between residue 101 and 110 as in C-type or L-type
BSE. When several available N-terminus-specific
antibodies were compared for their affinity to the
different types of BSE and scrapie from sheep,
it became clear that only mAb 12B2 (binds to
PrP region 101–105) exhibited similar affinity to
PrPres of H-type BSE cases as core-specific antibo-
dies and N-terminus-specific antibodies 9A2 and
RB1, which bind to bovine PrP region 110–113
(Fig. 3). However, although P4 and 12B2 have sim-
Table 1. Ratios of diglycosylated to monoglycosylated
PrPres as indicator for L-type cases
BSE-group D=M ratio SD (range)
C-types (UK) 2.5 0.5 (2.0–3.6)
C-types (PL) 2.2 0.2 (1.9–2.6)
L-types 1.1 0.04 (1.1–1.2)
H-type 1.9
D=M ratio, ratio of percentage diglycosylated to monogly-
cosylated PrPres. Average values were taken for C-types UK,
C-types PL, L-types and H-type from 16, 41, 6, and 1 cases,
respectively. Western blots were immunostained with mAb
6H4, and several runs of each sample were tested. The
variation for the single H-type case in repeated analyses
was 1.9 0.1 (1.8–2.1), 6 runs.
Fig. 3. Antibody 12B2 as preferential tool for detection of
H-type BSE: PrPres N terminus (P4, 12B2, RB1 and 9A2)
and core specific antibodies (6H4 and 94B4) applied on
bovine and ovine brain samples. 1–3 and 7 Bovine brain
stem tissue. 5–6 ovine brain stem tissues. 1 L-type PL28, 2
C-type PL1, 3 H-type PL45, 4 molecular weight standard
(XP, Invitrogen, values in kDa), 5 scrapie, 6 undigested
ovine, 7 undigested bovine. Tissue equivalents: 0.5 mg=lane.
The epitopes of the antibodies 12B2, P4, 9A2 and RB1 are
very closely located in bovine PrP, namely at 101–105,
101–107, 110–112, and 110–113, respectively
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ilar epitope specificities [28], P4, in contrast to
12B2, bound only poorly PrPres and intact PrP from
cattle (see Fig. 3, lanes 3 and 7), while both anti-
bodies bound well to PrPres and intact PrP from
sheep (see Fig. 3, lanes 5 and 6).
Deglycosylation
Deglycosylation results obtained by digestion with
PNGase F showed that both the top and middle
bands of the triple band components of PrPres were
truly glycosylated in all BSE cases, since they were
absent after deglycosylation, and only a single non-
glycosylated form was observed (Fig. 4). A striking
phenomenon was that bands resulting from degly-
cosylation with PNGase F from all three types of
BSE were broader and thus exhibited an average
higher apparent mass (higher position on the blot)
than the nonglycosylated undigested counterparts
(compare lanes  and þ in Fig. 4). This suggests
a slightly different physical behaviour between non-
glycosylated PrPres after PK digestion only and
deglycosylated PrPres after additional enzymatic
deglycosylation with PNGase F.
Details about atypical cases
All seven atypical cases were initially detected dur-
ing active surveillance by means of one of two rap-
id tests in use at the time of screening in Poland
(Table 2). The cases were all older animals, 9–
13 years of age (mean age of 11 years), while classi-
cal BSE was found in animals 2–12 years old (mean
age of 7 years). None of these cases was reported to
have clinical signs, although this could not be fur-
ther investigated. All cases were thus detected by
rapid tests, indicating the suitability of these tests
for detection, despite the above-mentioned varia-
tions between the BSE types with respect to their
dependence on N-terminal epitopes and the migra-
tion of PrPres. Every case except case no. 2 had high
Fig. 4. Deglycosylation of three types of BSE subjected to
digestion with PNGase F. Antibody used for detection:
6H4 (0.2 mg=ml). Symbols:  nondigested samples, þ
digested samples, MW molecular weight standards. Applied
amounts: 0.3 mg of tissue equivalent per lane
Table 2. Detailed information on cases of atypical BSE diagnosed in Poland
Case no. BSE type Year
detected
Age (years)
at detection
Healtha
status
Rapid test results
(cut off)b
Confirmatory
test resultsc
2 L 2002 12.6 h.s. 5.56 (5.5) E þ=þ=þ
15 L 2004 9.4 h.s. 3.46 (0.22) B þ=þ=þ
17 L 2004 12.6 e.s. 3.38 (0.22) B NT=þ=þ
28 L 2005 11.2 h.s. 3.27 (0.23) B þ==þ
31 L 2005 13.2 f.s. 3.34 (0.22) B NT=þ=þ
43 L 2006 12.1 f.s. 0.821 (0.22) B NT=þ=þ
45 H 2006 10.2 h.s. 2.83 (0.22) B NT=þ=þ
a Health status at detection: h.s. healthy slaughter, e.s. emergency slaughter, f.s. fallen stock.
b Rapid test result: E Enfer TSE ELISA, B Biorad TeSeE ELISA.
c Confirmatory test results are from three tests: histopathology by HE staining and vacuoles, IHC and Western blot. A
modified Prionics Check Western procedure (digestion at 37 C for 60 min) was used in the Western blot. Symbols:þ positive,
 weakly positive, NT not tested.
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readings in the rapid test, although case no. 2 was
also strongly PrPres positive in subsequent analysis
by Western blot. All of the atypical cases were
confirmed using histopathology, immunohisto-
chemistry and=or modified Western blot, and each
case was clearly positive.
Discussion
The molecular data presented in this study clearly
show the existence of atypical BSE in older cattle
in Poland. Some special diagnostic features for
confirmatory discrimination from C-type cases are
presented, such as for L-type cases, a rather consis-
tent 1=1 ratio between the di- and monoglyco-
sylated PrPres fractions (D=M ratio) and for the
H-type case, the strong binding of the PrPres triplet
to an antibody, 12B2. The first atypical BSE case in
Poland was an L-type detected in 2002 and diag-
nosed as atypical in 2004 [31, 32]. Altogether in the
present study, until the end of 2006, seven BSE
cases (comprising 14% of all positives) were clas-
sified as atypicals based on their glycoprofile, mi-
gration pattern and antibody binding of PrPres. All
of those cases were diagnosed during active surveil-
lance, but analysis of PrPd distribution patterns in
different regions of the central nervous system was
impossible since only brain stem samples could be
obtained. The TSE strain status of some of these
cases is under investigation in bioassays.
The recognition of an atypical BSE status re-
quires a clear definition of classical forms of the
disease. Even though critical data on BSE-type clas-
sification by molecular PrPres analyses have been
described, two features are used here that would
better assist a robust typing than indicated in those
studies [25]. Firstly, as described, PrPres from clas-
sical BSE was considered to be characterized by a
predominance of the diglycosyl form, but this is
also the case in H-type cases. However for H-type
cases, this depends on the antibody used, and there-
fore the PrPres glycoprofile is a debatable indicator
for discrimination between H-type and C-type BSE.
However, L-type cases can be recognized based on
the criterium of the glycoprofile due to the high
relative fraction of non- and mono-glycosylated
PrPres. While variations were observed in terms of
percentage values of PrPres glycoforms, in cases
analyzed, the ratio between diglycosylated and
monoglycosylated PrPres (D=M) proved to be a
very reliable indicator for recognition of L-types
(Table 1). The D=M ratios for all British and
Polish C-type cases analyzed were 1.9 and higher.
The H-type case also exhibited a C-type-like D=M
ratio (values between 1.8 and 2.1). Remarkably, the
six L-type cases had consistently low D=M ratios,
between 1.1 and 1.2, with little variation between
and within cases. Secondly, as expected, the slower
migration of PrPres bands was the most conspicuous
tool for detection of the H-type case, as also ob-
served previously [6, 14, 25]. This migration fea-
ture was very clear with both N-terminus-specific
antibodies (9A2, RB1) and core-specific antibodies
like 6H4 and 94B4. While migration differences
between runs often yield different Mr values,
antibody reactivities remain independent of such
fluctuations. It was shown here however, that for
immunochemical discrimination between H-type
and C-type, antibody 12B2 was the most powerful,
since only with the H-type case did the antibody
yield approximately equal signals in density com-
pared to antibodies 6H4, 9A2, and 94B4. Antibody
P4, with a somewhat larger epitope requirement
than 12B2, was subject to species-dependent se-
quence variations which made it a less suitable can-
didate for application to bovine PrP.
Migration differences between C-type PrPres and
atypical cases were in agreement with published
observations. When using core-specific antibody
6H4, the difference between H-type and C-type
was estimated to be 0.9–1.2 kDa larger PrPres mole-
cules for H-type than C-type. In contrast, PrPres
molecules of L-type cases within single experi-
ments were consistently up to 0.5 kDa smaller than
those of C-type cases. This faster migration, espe-
cially of the nonglycosylated band, has been de-
scribed as one of the key features of BASE or
L-type cases of BSE [17], but our experience shows
that it may be difficult to notice this difference un-
der standard WB conditions. A similar conclusion
was drawn from a German L-type case, where the
only clear difference from classical BSE was the
predominance of the diglycosylated form of PrPres
[14]. With N-terminus-specific antibody 9A2, the
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migration pattern of the L-type was even indis-
tinguishable from C-type cases, which can be
explained by the fact that cleavage of PrPres in L-
type cases by proteinase K occurs directly at and in
the epitope of this antibody (residue 110–112) so
that only the larger size population can be visual-
ised, while core-specific antibodies bind to both
shorter and larger-size PrPres populations.
A common feature of all atypical cases was the
higher age of affected individuals (9–13 years)
compared to classical BSE found in various age
groups (2–12 years). Opposite to our findings, first
in Japan and then in Belgium, atypical cases of
BSE were found in younger cattle [21, 42]. The
Japanese case was found in a 23-month-old steer,
while the Belgian cow was 64 months old. Further
studies performed in other countries where atypical
BSE was found (France, Italy, Germany, Sweden,
The Netherlands, USA) showed that only older cat-
tle (8 years and older) were affected [25, 35]. While
most of these cases could be properly identified,
comparing cases described in Japan and Belgium
with atypical BSE found in Europe, one can pre-
sume that those were L-types due to a low content
of the diglycosylated form and faster migration
of the nonglycosylated moiety of PrPres. An addi-
tional feature found in the Japanese case, namely
less resistance to PK digestion in comparison to
classical BSE, resembled atypical scrapie [4, 13].
However, comparison between studies for glyco-
profiles can only properly be performed with the
same reference samples for comparisons and us-
ing similar antibody conditions. The identity of
the BSE type cannot be confirmed, either for the
Belgian or the Japanese case since histopahological
and immunohistochemical data are lacking, while
all Polish atypical cases were confirmed by at least
two confirmatory methods. Further collaborative
studies within the NeuroPrion network of excel-
lence in Europe on atypical cases of BSE has en-
abled the distinction of L-type BSE with molecular
features similar to BASE, and H-type BSE in sev-
eral countries with a practical approach for the
identification of such cases [25]. Our six Polish
cases described had similar molecular characteris-
tics of PrPres to Italian BASE and all of them could
be assigned to L-type BSE.
Atypical cases in Poland were found almost
equally in both healthy (57%) and risk-group
(43%) cattle, but the majority of classical BSE in
Poland belonged to the healthy slaughtered group
(79%), which is probably directly correlated with
testing volume (majority of tested samples coming
from healthy slaughtered animals). Therefore, de-
spite testing mostly healthy slaughtered animals,
atypical BSE seems to be dominant in risk-group
cattle. But this hypothesis can only be properly
tested when more atypical cases have been found.
The percentage of samples tested in Poland from
animals 8 years and older comprised 1% in 2002,
23% in 2003, 52% in 2004, 54% in 2005, and 53%
in 2006. Therefore, it can be speculated that the
relatively high number of L-type BSE in Poland
may be correlated with a high percentage of older
cattle tested within the active surveillance scheme.
Despite the constantly growing number of samples
tested in 2004–2006 (increase from 481,116 sam-
ples tested in 2004 to 625,438 samples tested in
2006), only 2 atypical cases were found per year.
When geographical distribution was taken into ac-
count, atypical cases were predominant in eastern
Poland (5 out of 7 cases comprising 71%), while
the remaining 2 cases were located in the central
part. Classical BSE was distributed more evenly,
with 44% in the central part, 30% in the eastern
part, and 26% in the western part of Poland.
Polish atypical cases require more detailed analysis
in relation to geographical distribution and other
factors before any general statement related to epi-
demiology or risk can be made.
Clarification of whether these atypical cases rep-
resent genuine strains of BSE would be accom-
plished by transmission studies in mice. Such
studies have already been performed in France,
Germany and Italy [3, 5, 14, 15]. For H-type cases
in France, successful transmission was achieved in
both wild-type, and transgenic mice expressing bo-
vine and ovine PrPC. In Germany, successful trans-
mission of both an L-type and an H-type case to
transgenic mice overexpressing bovine PrPC has
been described. PrPres from those mice was identi-
cal to the inoculum used in the study, proving the
existence of distinct strains of BSE. All atypical
features of those isolates were maintained in the
76 M. P. Polak et al.
inoculated mice, indicating the existence of several
prion strains in cattle, or alternatively a possible
evolution to a single BSE strain, as suggested from
data obtained by Capobianco et al. with wild-type
inbred mice [15]. This second hypothesis could fit
with data from the United Kingdom, where over
180,000 cases of BSE were diagnosed by passive
surveillance. British and European experience based
on tissue analysis from clinically affected animals
showed consistent characteristics of BSE agent not
only on histological sections from cattle brains but
also when inoculating mice, pointing to the exis-
tence of one uniform strain of BSE. Therefore, it is
possible that a sporadic form of BSE present in the
cattle population at a very low rate in the past could
have spread to naive animals via contaminated meat-
and-bone meals. Spontaneous BSE, if it occurs,
must be a very rare phenomenon. However, data
for Poland, where 14% of all cases comprised an
atypical form of BSE, seems to be in contradiction
to this hypothesis. But when the average age of all
positive cases in Poland is taken into account, BSE
is generally found in older animals (mean age of
7.7). Analysis of the age structure of cattle in
Poland in the period of 2002–2006 shows that
56–60% of all animals were 7 years old and above.
A much larger number of cattle should be tested to
get better insight into the real prevalence of atypical
BSE. However, current tendencies based on eco-
nomic analysis point to a decrease in the number
of tests performed rather than expanding this
scheme any further. It would be sensible to main-
tain a certain level of testing focused on the older
age group to distinguish between a stable, thus spo-
radic-based, situation of BSE, or alternatively a
fade-out, thus epidemic-based, situation. Exploring
the subject of spontaneous BSE in the cattle pop-
ulation may be ceased for economic reasons, and
it may never be known while this answer is in
our reach thanks to great financial efforts in recent
years.
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